Meta AnalysisID 4525
慢性阻塞性肺疾病吸入糖皮质激素基础上加用茶碱：系统评价与Meta分析方案
CRD42021224952
To study the efficacy and safety of adding theophylline to ICS therapy in the treatment of COPD patients
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 4525
- Evidence Id
- 13083
- Core Evidence Id
- 13083
- Source Meta Analysis Id
- 4494
- Herb2 Meta Analysis Id
- HBMA004494
- Crd Id
- CRD42021224952
- Title
- Adding theophylline to ICS therapy on COPD: a protocol for systematic review and meta-analysis
- Review Question
- To study the efficacy and safety of adding theophylline to ICS therapy in the treatment of COPD patients
- Study Type Included
- Any comparative study, i.e., cohort, case-control, RCTs
- Condition Being Studied
- Chronic obstructive pulmonary disease (COPD) is a common and frequently occurring respiratory disease. A preventable and treatable disease characterized by limited airflow, associated with abnormal inflammatory responses of the lungs to harmful particles or gases, and COPD may also affect changes in various systems throughout the body, thus having systemic effects.
- Participant
- Patients with chronic obstructive pulmonary disease
- Animal
- Human Disease Modelled
- Intervention
- theophylline to ICS therapy
- Comparator Control
- ICS therapy
- Main Outcome
- Severe COPD exacerbations, COPD hospital admissions, health-related quality-of-life score, total admissions, FEV1, FVC, MVV, CAT, mMRC, pneumonia, all-cause mortality, COPD-related mortality and adverse effects. Measures of effect Mean difference, odds ratio (OR) or relative risks (RR)
- Outcome Measure
- Additional Outcome
- None Measures of effect None
- Study Method
- Intervention, Meta-analysis, Systematic review
- Keyword
- Administration, Inhalation; Humans; Meta-Analysis as Topic; Pulmonary Disease, Chronic Obstructive; Systematic Reviews as Topic; Theophylline
- Contact
- Lufang Feng [email protected]
- Organisational Affiliation
- Lanzhou university
- Funding Source
- No
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Completed published
- First Submission Date
- 2020-12-13
- Registration Date
- 2021-01-13
- Anticipated Start Date
- 2020-12-20
- Anticipated Completion Date
- 2021-06-01
- Title Cn
- 慢性阻塞性肺疾病吸入糖皮质激素基础上加用茶碱：系统评价与Meta分析方案
- Title En
- Adding theophylline to ICS therapy on COPD: a protocol for systematic review and meta-analysis
- Bilingual Status
- complete